While our recent study suggested that GPC-1 acts as a tumor suppressor, it is not known if GPC-1 plays a direct role in modulating the activation of stromal cell components, such as fibroblasts, in prostate cancer. The gene discussed is GPC1; the disease is prostate carcinoma.